Quantcast

Latest Brain tumor Stories

2014-05-16 12:20:36

UC Health News Just because you can’t see something doesn’t mean it’s not there. Brain tumors are an extremely serious example of this and are not only difficult to treat—both adult and pediatric patients have a five-year survival rate of only 30 percent—but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process. However, Cincinnati Cancer Center research studies published in an April online issue...

2014-05-16 08:26:16

30mg/m2 dose cohort had been completed; enrollment of 40mg/m2 cohort has been initiated VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") is pleased to provide an update on the company's ongoing Phase I/II clinical trial for VAL-083 in recurrent glioblastoma multiforme (GBM). DelMar has completed enrollment of VAL-083 dose Cohort 6 and advanced to Cohort 7. DelMar most recently presented...

2014-05-15 23:13:19

May is brain tumor awareness month. ANS in Morristown discusses Next-Generation Treatments, Community Awareness and their program Partnership of Hope. Morristown, NJ (PRWEB) May 15, 2014 Brain tumors are the second leading cause of cancer related deaths in children and young adults ages 15- 34. For over 50 years, Atlantic NeuroSurgical Specialists (ANS) has maintained their core value that the needs of their patients come first. This means constantly striving toward the application of...

2014-05-15 23:01:53

Advances in Neuroblastoma Research Association Recognizes Physician-Investigator's Progress Against a Challenging Childhood Cancer Philadelphia, Pa (PRWEB) May 15, 2014 The Advances in Neuroblastoma Research Association (ANRA) is conferring its highest honor on pediatric oncologist Garrett M. Brodeur, M.D., of the Cancer Center at The Children’s Hospital of Philadelphia (CHOP). Brodeur will receive the ANRA Lifetime Achievement Award tomorrow at the association’s international...

2014-05-15 08:32:30

First Case Study Announced While Broader Data Being Collected; Evidence Indicates Substantial Tumor Necrosis and Initial Tumor Regression BETHESDA, Md., May 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today provided an initial patient case study, showing signs of tumor necrosis (tumor death) and initial tumor regression, from the Company's ongoing...

2014-05-14 20:23:34

VANCOUVER, British Columbia and MENLO PARK, Calif., May 14, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company will present an abstract entitled, "Phase I/II study of dianhydrogalactitol (VAL-083) in patients with recurrent malignant glioblastoma multiforme (GBM)," at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held May 30th to June 3rd at the McCormick Place Convention Center in...

2014-05-13 08:33:29

Patients with five to 10 metastatic brain tumors who receive Gamma Knife radiosurgery live as long as those with two to four tumors post-therapy NEW YORK, May 13, 2014 /PRNewswire/ -- A Japanese multi-institutional study(1) of 1,194 patients, has found that individuals with five to 10 tumors treated with Gamma Knife® stereotactic radiosurgery alone (no whole brain radiation therapy) fared as well as a group with two to four tumors who received this radiosurgery-only treatment. The...

2014-05-12 23:02:15

First Ever Nursing Clinical Guidelines for Brain Tumor Patients Released from the ABTA and AANN Chicago, IL (PRWEB) May 12, 2014 To meet the unique needs of brain tumor patients, the American Brain Tumor Association (ABTA) and the American Association of Neuroscience Nurses (AANN) announce the availability of the first ever clinical practice guidelines (CPG) for the treatment of adults with brain tumors. The Care of the Adult Patient with a Brain Tumor Clinical Practice Guideline was...

2014-05-09 23:08:37

Leader of patient support organization travels to the nation’s capital to ensure access to emerging FDA-approved therapies for all brain tumor patients. Seattle, WA (PRWEB) May 09, 2014 For a second time this year, Dellann Elliott Mydland, CEO & President of the Pacific Northwest-based Chris Elliott Fund, is traveling to the opposite coast to advocate on behalf of brain tumor patients across the United States. The purpose of this trip is to ensure access for all cancer patients to...

2014-05-08 12:29:37

Tumors shrank or disappeared in some patients with advanced neuroblastoma in a Phase I study of an immune therapy manufactured at St. Jude Children's Research Hospital MEMPHIS, Tenn., May 8, 2014 /PRNewswire-USNewswire/ -- Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital. Four patients are still alive after more...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related